Evaluating recovery in stroke patients treated with thrombectomy
Evaluation of Favorable Functional Recovery Predictors at 3 Months of Patients With Acute Ischemic Stroke Treated by Mechanical Thrombectomy
This study looks at how well stroke patients recover after a procedure that removes blood clots to see what factors might help them get better in the first three months.
Quick facts
| Study type | Observational |
|---|---|
| Enrollment | 540 (estimated) |
| Ages | 18 Years and up |
| Sex | All |
| Sponsor | University Hospital, Montpellier Academic / other |
| Locations | 1 site (Montpellier) |
| Trial ID | NCT04916782 on ClinicalTrials.gov |
What this trial studies
This observational study aims to assess the functional recovery of patients with acute ischemic stroke who are treated with mechanical thrombectomy. It will analyze various factors that may predict successful recovery at three months post-treatment, including the timing of the procedure, patient age, and the type of anesthesia used. The study will also evaluate the impact of radiological metrics on patient management and outcomes. By identifying characteristics of 'good responder' patients, the research seeks to enhance treatment protocols for stroke patients.
Who should consider this trial
Good fit: Ideal candidates for this study are adults aged 18 and older who require mechanical thrombectomy for acute ischemic stroke.
Not a fit: Patients with serious concurrent illnesses affecting short-term prognosis or those unable to complete follow-up will not benefit from this study.
Why it matters
Potential benefit: If successful, this study could improve patient selection and treatment outcomes for individuals suffering from acute ischemic stroke.
How similar studies have performed: Previous studies have shown the efficacy of mechanical thrombectomy in younger patients, but this study aims to provide new insights, particularly for older patients, making it a novel approach.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria: * Age ≥ 18 years * Indication for treatment with Mechanical Thrombectomy * Imaging on admission (Scanner and/or Magnetic Resonance Imaging (MRI)) showing occlusion of a large intracranial artery intracranial artery (anterior, middle, posterior cerebral artery, basilar artery, vertebral vertebral artery) * Health insurance coverage * Obtaining the patient's consent Exclusion Criteria: * Patient with a serious intercurrent pathology impacting the vital prognosis in the short term and making it impossible to follow up at 3 months. * Patients for whom follow-up will be impossible (foreign tourists) * Patients of legal age (under guardianship, under curatorship, deprived of liberty)
Where this trial is running
Montpellier
- University Hospital of Montpellier — Montpellier, France (Recruiting)
Study contacts
- Study coordinator: Cyril Dargazanli
- Email: c-dargazanli@chu-montpellier.fr
- Phone: 04.67.33.75.32
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.